Home Search

To improve corona vaccine manufacturing system Takara Bio, investment of 9.5 billion yen possibility to expand mass production - search results

If you're not happy with the results, please do another search

World news –JP –Corona vaccine manufacturing system development Takara Bio invests 9.5 billion yen...

On the 10th, Takara Bio's president Koichi Nakao invested 9.5 billion yen in a new research and manufacturing facility for regenerative medicine products that started operation in January on the premises of the head office in Kusatsu City, Shiga Prefecture.ja